Company

T3D Therapeutics

As of the edition of 20 October 2026, T3D Therapeutics runs 1 drug.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active1
Total1

Where its trials are

  • Mental health: 3 trials led
  • Nervous system: 3 trials led